Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23791 ↗At a glance
Übersichtsarbeit in Molecular Carcinogenesis, 2024. Written by Xing Ma and 7 co-authors. Institution: Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. Major MEDLINE topics: Cholangiocarcinoma, Bile Duct Neoplasms, Protein Serine-Threonine Kinases, Hippo Signaling Pathway. Cited 1 times so far (Crossref); 67 references. Funded by: Henan Medical Science and Technology Breakthrough Plan.
Abstract (original language)
The tumorigenesis of intrahepatic cholangiocarcinoma (ICC) has been identified to be exceptionally involved in dysregulated Hippo/Yes‐associated protein (YAP) signaling pathway (Hippo/YAP). Hippo/YAP functions as a master regulator engaged in a plethora of physiological and oncogenic processes as well. Therefore, the aberrant Hippo/YAP could serve as an Achilles' heel regarding the molecular therapeutic avenues for ICC patients. Herein, we comprehensively review the recent studies about the underlying mechanism of disrupted Hippo/YAP in ICC, how diagnostic values could be utilized upon the critical genes in this pathway, and what opportunities could be given upon this target pathway.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
- Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID profiles: Xing Ma
Funding
- Henan Medical Science and Technology Breakthrough Plan
Cite
APA
Ma, X., Zhou, Y., Li, R., Ding, X., Li, D., Pan, T., Zhang, F., & Li, W. (2024). Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23791
Vancouver
Ma X, Zhou Y, Li R, Ding X, Li D, Pan T, et al. Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23791
BibTeX
@article{Ma2024,
author = {Ma, Xing and Zhou, Yangyang and Li, Ruping and Ding, Xianmin and Li, Deyu and Pan, Tingting and Zhang, Fuqiang and Li, Wenliang},
title = {Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23791}
}
EUVIMED